Hawaii Biotech Inc.;Infectious Disease Research Institute
发明人:
David E. Clements,Neal Van Hoeven
申请号:
US16315986
公开号:
US20190298819A1
申请日:
2017.07.07
申请国别(地区):
US
年份:
2019
代理人:
摘要:
A West Nile virus (WNV) vaccine for human use is described that contains a recombinantly produced form of truncated WNV envelope glycoprotein and a combination of a Toll-like receptor 4 (TLR-4) and saponin adjuvants. A pharmaceutically acceptable vehicle may also be included in the vaccine.